Category Archives: For Employers

Drawing on our executive search practice, we put this together to give employers a grounded, practical view they can act on. Many pharmaceutical organisations face a concentration of senior expertise in leaders approaching retirement, particularly in regulatory, quality, […]

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. A VP of Regulatory Affairs in a global pharmaceutical company must manage submissions and lifecycle obligations across jurisdictions whose requirements, […]

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Confidential searches are common in pharmaceutical C-suite hiring, usually because an incumbent is still in post, because the search itself would signal […]

At JRG Partners, this is the kind of search we run every day, so this piece reflects practice rather than theory. Generic drug manufacturing runs on a fundamentally different economic model from innovator pharma: margins are thin, competition is price-driven, speed to market […]

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Building a commercial launch team means assembling capabilities in the right order, well before approval, for a product whose final label, timing, and […]

This reflects what we have learned at JRG Partners doing exactly this kind of work, the distinctions that matter and the mistakes that recur. Executives who have operated credibly in both innovator and generic pharmaceutical businesses are genuinely scarce, and increasingly […]

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Pharmaceutical executive search is unusually demanding because assessing candidates requires understanding science, regulation, development strategy, […]

At JRG Partners, this is the kind of search we run every day, so this piece reflects practice rather than theory. A pharmaceutical CFO operates in a business where intellectual property is often the principal asset, patent expiry defines the revenue horizon, and litigation […]

Drawing on our executive search practice, we put this together to give employers a grounded, practical view they can act on. Pharmaceutical mergers routinely destroy more value through talent loss than through any operational difficulty, because the scientific and regulatory […]